Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 15:60:56-60.
doi: 10.1016/j.amsu.2020.10.005. eCollection 2020 Dec.

Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study

Affiliations

Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study

Yanri Wijayanti Subronto et al. Ann Med Surg (Lond). .

Abstract

Introduction: Indonesia antiretroviral therapy guideline suggests the use of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based regiments as first line of HIV treatment and Protease Inhibitor to replace NNRTI when treatment failure occurred. This case-control study was aimed to study factors predicting first-line ART treatment failure among HIV positive patients aged >15 years, non-pregnant, and registered in our institution, Indonesia.

Methods: Diagnosis of HIV treatment failure was made according to the standard WHO criteria. Demographic and outcome variables were recorded. The association between variables were analyzed by Chi-square test with odds ratios (OR) and 95% confidence intervals (95% CI), followed by multivariate analysis using logistic regression test.

Results: Twenty-six index cases and 26 age- and sex-matched control cases were included in the study with a mean age of 32.27 ± 8.7 years and 32.88 ± 8.15 years, respectively. Median time for switching to second-line (Lopinavir/ritonavir, LPV/r) was 46.32 ± 30.21 months. Patients presented with tuberculosis and treated by nevirapine as the first-line treatment were 26.6-folds (95% CI: 2.41-293.81, p = 0.007) and 6.7-folds (95% CI: 1.56-28.45, p = 0.011) higher risk for treatment failure, respectively.

Conclusions: The presence of tuberculosis and the use of nevirapine in first-line treatment were strong predictors for first-line ARV treatment failure, suggesting for closer clinical monitoring for patients with those conditions. A further and larger prospective cohort study is needed to confirm the findings in this study.

Keywords: ART treatment failure; HIV; Indonesia; Nevirapine; Predicting factors; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest.

Similar articles

Cited by

References

    1. Who . 2013 June. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach June 2013. - PubMed
    1. UNAIDS . e; 2018. Miles to go: closing gaps, breaking barrier, righting justic.https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf Available from:
    1. Tsegaye A.T., Wubshet M., Awoke T., Addis Alene K. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study. BMJ Open. 2016;6 - PMC - PubMed
    1. Asad S., Hulgan T., Raffanti S.P., Dougherty J., Ray W., Sterling T.R. Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors. J. Natl. Med. Assoc. 2008;100(12):1417–1424. - PMC - PubMed
    1. Agha R., Abdall-Razak A., Crossley E., Dowlut N., Iosifidis C., Mathew G. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int. J. Surg. 2019;72:156–165. - PubMed